Cerus Corporation (NASDAQ:CERS) has a beta of 1.24. The stock’s Relative Strength Index (RSI) is 47.82, with weekly volatility at 4.10% and ATR at 0.24. The CERS stock’s 52-week price range has touched low of $5.15 and a $8.87 high. Its shares traded lower over the last trading session, losing -3.22% on 06/18/21. The shares fell to a low of $5.71 before closing at $5.71. Intraday shares traded counted 3.89 million, which was -108.1% lower than its 30-day average trading volume of 1.87M. CERS’s previous close was $5.90 while the outstanding shares total 168.82M.
Investors have identified the Biotechnology company Cerus Corporation as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $1.01 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Cerus Corporation (CERS) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For CERS, the company has in raw cash 57.61 million on their books with 9.94 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on an incline. In terms of their assets, the company currently has 181.27 million total, with 54.76 million as their total liabilities.
CERS were able to record -18.17 million as free cash flow during the 08/05/2021 quarter of the year, this saw their quarterly net cash flow reduce by 20.9 million. In cash movements, the company had a total of -17.98 million as operating cash flow.
Potential earnings growth for Cerus Corporation (CERS)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the 08/05/2021 quarter of the year, Cerus Corporation recorded a total of 29.57 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 16.66% coming in sequential stages and their sales for the 08/05/2021 quarter reducing by -13.61%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 11.1 million trying to sell their products during the last quarter, with the result yielding a gross income of 18.47 million. This allows shareholders to hold on to 168.82M with the recently reported earning now reading -0.10 cents per share. This is a figure that compared to analyst’s prediction for their 08/05/2021 (-0.10 cents a share).
Having a look at the company’s valuation, the company is expected to record -0.31 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on CERS sounds very interesting.
Is the stock of CERS attractive?
In related news, Director, Swisher Daniel N JR sold 5,000 shares of the company’s stock in a transaction that recorded on May 18. The sale was performed at an average price of 5.75, for a total value of 28,735. As the sale deal closes, the Chief Operating Officer, Jayaraman Vivek K now sold 37,149 shares of the company’s stock, valued at 236,925. Also, Chief Financial Officer, Green Kevin Dennis sold 29,331 shares of the company’s stock in a deal that was recorded on Mar 15. The shares were price at an average price of 6.38 per share, with a total market value of 187,064. Following this completion of acquisition, the President and CEO, Greenman William Mariner now holds 156,407 shares of the company’s stock, valued at 997,517. In the last 6 months, insiders have changed their ownership in shares of company stock by 2.70%.
5 out of 5 analysts covering the stock have rated it a Buy, while 0 have maintained a Hold recommendation on Cerus Corporation. 0 analysts has assigned a Sell rating on the CERS stock. The 12-month mean consensus price target for the company’s shares has been set at $9.10.